Pharma Marketing Network

Recently, some pharmaceutical companies have stepped up their use of unbranded DTC ads whose messages focus only on the medical condition -- e,g., erectile...

This conference brings together leading industry experts and advanced practitioners to examine the steps companies have taken to map out their early stage commercialization processes.

Leverage Pre and Post Launch Market Research Strategies to Improve Initial Product Positioning and Ongoing Strategic Decision Making

On March 31, I posted a critique of the Coalition for Health Communication's (CHC's) petition to the FDA, the aim of which I said...

According to the Wall Street Journal, "Merck was ordered to pay $9 million in punitive damages to a man who had a heart attack...

Our 2006 conference presents solutions for effectively implementing successful compliance programs where patients, pharmacists, nurses, community leaders and physicians take ownership in improving compliance.

For months I have been receiving "personal emails" from Peter Rost -- Pharma's Black Knight -- informing me of his latest trials and tribulations...

Medical Marketing & Media (MM&M), one of the more interesting industry magazines, just printed a piece by my friend and colleague, Harry Sweeney, called...

Featured Conference 4th Annual Pharmaceutical Marketing & Sales Summit April 4 - 5, 2006 * Hyatt...

In one fell swoop the new erectile dysfuntion (ED) 'disease awareness' ads have expanded the market for ED while at the same time managed to come up smelling like roses by complying with PhRMA's Guiding Principles for DTC Advertising. 'Disease mongering' (aka, 'indication bloat') -- or, if you prefer, 'disease awareness'-- efforts are a rising tide that will float all ED drug ships.